Cost-utility analysis of icosapent ethyl in patients with high triglyceride levels and recent acute coronary syndrome in Catalonia
IPE appears to be a cost-effective intervention for high-risk patients with elevated TG and recent ACS in Catalonia. While limitations related to model assumptions, data extrapolation, and partial adaptation to local clinical practice exist, the findings remain consistent with international evidence and suggest that IPE could be a cost-effective intervention in Catalonia, offering a valuable opportunity to optimize healthcare resource allocation in the management of high-risk CV populations.
Authors
- J. Montaño (ORCID: https://orcid.org/0000-0001-6731-9081)
- Josep Comín‐Colet (ORCID: https://orcid.org/0000-0001-8780-720X)
- G. Vitale
- Román Freixa‐Pamias (ORCID: https://orcid.org/0000-0001-5301-4236)
- Núria García-Muñoz (ORCID: https://orcid.org/0000-0002-6169-8428)
- Sabine Gaugris
- Salvador García López (ORCID: https://orcid.org/0000-0003-0337-7295)
- Chetan Mistry
- Laurence Tilley
- Maria Mallén-Alberdi
Institutions
- CNH Industrial (Czechia) (CZ)
- Bellvitge University Hospital (ES)
- Centro de Investigación en Red en Enfermedades Cardiovasculares (ES)
- Centro de Investigación Biomédica en Red (ES)
- Hospital de Sant Joan Despí Moisès Broggi (ES)
- Amarin (United Kingdom) (GB)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1080/13696998.2025.2557717
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00